Category: Center for Integrative Chemical Biology and Drug Discovery

Former GSK Exec to Lead UNC Drug Discovery Center

October 12, 2007

Stephen Frye, PhD, former worldwide head of discovery, medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill. “The days when large pharmaceutical companies could be solely relied on to effectively translate basic research into new medicines are passing,” Frye said. “Academic science will have to rise to the challenge.” Frye is co-inventor of GSK’s Avodart, a drug used to shrink an enlarged prostate gland that is also under study for prevention of prostate cancer. Prior to his most recent role at GSK, his department … Read more

---